Overview
Updated 14 Jul 2026
David R. Spigel, M.D., is President and Chief Medical Officer, Sarah Cannon Research Institute (effective January 2026. The public record shows 909 publications with 79,383 citations (h-index 99), centered on Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies. It also documents an investigator role on 39 registered clinical trials, industry payments reported by 50 companies.
- Most recent indexed publication: 2026 · JCO precision oncology
- Top research focus: Lung Cancer Treatments and Mutations
- 39 registered trials on ClinicalTrials.gov
- Open Payments reporting from 50 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID; 28 in PubMed.
Total citations across indexed works.
Hirsch index (OpenAlex). i10-index 371.
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Public positionssourced statements on record
- Editor for Targeted Therapies
Oncology & Biotech News, Contemporary Oncology, and World Journal of Clinical Oncology; peer reviewer for numerous other journals (per secondary source …
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →mesothelioma.net ↗
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 39 registered studies on ClinicalTrials.gov. The most recent:
- Phase III Study to Determine Efficacy of Durvalumab in Stage II-III Non-small Cell Lung Cancer (NSCLC) After Curative Intent Therapy.
Sponsor: AstraZeneca
InvestigatorPhase 3CompletedNCT04642469 - Study of Lanreotide in Patients With Metastatic Gastrointestinal Neuroendocrine Tumors Who Are Undergoing Liver-directed Radioembolization With Yttrium-90 Microspheres
Sponsor: SCRI Development Innovations, LLC
InvestigatorPhase 2TerminatedNCT02859064 - Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers
Sponsor: SCRI Development Innovations, LLC
InvestigatorPhase 2CompletedNCT02318784
Industry payments
Updated 14 Jul 2026
50 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- E.R. Squibb & Sons, L.L.C.Program year202514 payments$12,752openpaymentsdata.cms.gov ↗
- GlaxoSmithKline, LLC.Program year20253 payments
- ABBVIE INC.Program year20254 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
Updated 14 Jul 2026
Their five most recent publications, matched to their ORCID record and linked to PubMed.
Most-cited worksby citation count (OpenAlex)
- 01Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer12,657 citations2012
- 02
- 03
- 04Overall Survival with Durvalumab after Chemoradiotherapy in Stage III NSCLC2,802 citations2018
- 05Atezolizumab for First-Line Treatment of PD-L1–Selected Patients with NSCLC1,692 citations2020
Contact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
Telephone
Practice address and telephone from the federal NPPES registry.
Sign in to view contact details →Network
Updated 14 Jul 2026
The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
- Internal Medicine residency and chief residency
Indiana University School of Medicine
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →centennialmedicine.com ↗ - Fellowship in Hematology/Oncology
Dana-Farber Cancer Institute, Boston
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →centennialmedicine.com ↗ - verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
Editorial & leadership rolesjournal and society appointments
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →scri.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →centennialmedicine.com ↗
Secondary affiliationsappointments beyond the home institution
- Board member
Association of Community Cancer Centers (ACCC)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →centennialmedicine.com ↗ - Member
American Society of Clinical Oncology (ASCO)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →centennialmedicine.com ↗ - Member
American Association for Cancer Research (AACR)
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →centennialmedicine.com ↗
Media & interviewspress, podcasts and appearances
- Podcast guest
"The Research Evangelist," Episode 43 (2021), profiled as thoracic medical oncologist and Chief Scientific Officer, Sarah Cannon Research Institute
2021verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchevangelist.com ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →onclive.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →targetedonc.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- ResearchGate
researchgate.net/scientific-contributions/D-R-Spigel-2099152522
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →researchgate.net ↗ - X / Twitter
x.com/davidrspigel
- Doximity
doximity.com/pub/david-spigel-md
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →doximity.com ↗
Mentions by otherswhere others cite or feature them
- Facebook
facebook.com/sarahcannonresearch/videos/june-is-cancer-immunotherapy-month-and-dr-david-spigel-of-sarah-cannon-research-/2420270155023501
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →facebook.com ↗ - Instagram
instagram.com/reel/DL-3ZNFsEuH
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - LinkedIn
linkedin.com/company/sarah-cannon-research-institute
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.